Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications.
Expert Rev Pharmacoecon Outcomes Res
; 21(4): 527-540, 2021 Aug.
Article
in En
| MEDLINE
| ID: mdl-33535841
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Drug Costs
/
Delivery of Health Care
/
Neoplasms
/
Antineoplastic Agents
Type of study:
Health_economic_evaluation
/
Prognostic_studies
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Expert Rev Pharmacoecon Outcomes Res
Journal subject:
FARMACOLOGIA
Year:
2021
Type:
Article
Affiliation country:
Sweden